These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 9865500)

  • 21. Synthesis and anti-inflammatory activity of alkyl/arylidene-2-aminobenzothiazoles and 1-benzothiazol-2-yl-3-chloro-4-substituted-azetidin-2-ones.
    Khedekar PB; Bahekar RH; Chopade RS; Umathe SN; Rao AR; Bhusari KP
    Arzneimittelforschung; 2003; 53(9):640-7. PubMed ID: 14558438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
    Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
    J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
    Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
    Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation.
    Wallace JL; Chapman K; McKnight W
    Br J Pharmacol; 1999 Mar; 126(5):1200-4. PubMed ID: 10205009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
    Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
    Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a Korean traditional formulation, Hwaotang, on superoxide generation in human neutrophils, platelet aggregation in human blood, and nitric oxide, prostaglandin E2 production and paw oedema induced by carrageenan in mice.
    Park WH; Park SY; Kim HM; Kim CH
    Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):53-73. PubMed ID: 15106732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: effects of flosulide.
    Turull A; Queralt J
    Prostaglandins Other Lipid Mediat; 2001 Aug; 66(1):27-37. PubMed ID: 11519792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium.
    Selvam C; Jachak SM
    J Ethnopharmacol; 2004 Dec; 95(2-3):209-12. PubMed ID: 15507338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
    Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
    Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental investigation and molecular simulations of quinone related compounds as COX/LOX inhibitors.
    Chaaban I; Hafez H; Hazzaa A; Domiati S; Abd El Galil KH; Hdeib F; Belal ASF; Ragab H
    Inflammopharmacology; 2024 Aug; 32(4):2395-2411. PubMed ID: 38858336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2.
    Lazer ES; Sorcek R; Cywin CL; Thome D; Possanza GJ; Graham AG; Churchill L
    Bioorg Med Chem Lett; 1998 May; 8(10):1181-6. PubMed ID: 9871731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
    Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel functions of bovine milk-derived alpha-lactalbumin: anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2.
    Yamaguchi M; Yoshida K; Uchida M
    Biol Pharm Bull; 2009 Mar; 32(3):366-71. PubMed ID: 19252279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.
    Khanna IK; Weier RM; Yu Y; Collins PW; Miyashiro JM; Koboldt CM; Veenhuizen AW; Currie JL; Seibert K; Isakson PC
    J Med Chem; 1997 May; 40(11):1619-33. PubMed ID: 9171872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
    Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
    Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.